MB "IVB Pharma Consulting" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 247,936 |
| 122,741 |
| 84,649 |
| 80,275 |
| 39,740 |
| 85.63 |
| 32.38 |
| 145,620 |
| 41,662 |
| 17,171 |
| 170,111 |
| 2023 |
|---|
| 223,245 |
| 212,614 |
| 100,459 |
| 95,927 |
| 91,359 |
| 75.62 |
| 42.97 |
| 183,659 |
| 16,590 |
| 0 |
| 200,249 |
| 2024 |
|---|
| 256,854 |
| 256,854 |
| 99,759 |
| 95,478 |
| 95,478 |
| 80.27 |
| 37.17 |
| 241,298 |
| 12,122 |
| 0 |
| 253,420 |
Register and
explore Okredo data| 2024 |
|---|
| 256,854 |
| 256,854 |
| 99,759 |
| 95,478 |
| 95,478 |
| 80.27 |
| 37.17 |
| 241,298 |
| 12,122 |
| 0 |
| 253,420 |
Register and
explore Okredo data2024
Turnover (€)
256,854 €
15 % *
Sales per employee (€)
256,854 €21 % *
Profit before tax (€)
99,759 €
-1 % *
Net Profit (€)
95,478 €0 % *
Profit per employee (€)
95,478 €5 % *
Total profitability (%)
80.27 %6.15 % *
Net profitability (%)
37.17 %-13.50 % *
Equity (€)
241,298 €31 % *
Amounts Payable And Liabilities (€)
12,122 €
-27 % *
Non-current Assets (€)
0 €
- *
CurrentAssets (€)
253,420 €
27 % *